Table 3 Comparisons on SF-36, SDS and SAS scores after the intervention
Domain | Average scores (\( \overline{X}\pm S \)) | t | p-value | |
|---|---|---|---|---|
G.H.3. (n = 48) | Placebo (n = 50) | |||
PF | 75.73 ± 22.17 | 72.90 ± 24.68 | 0.596 | 0.552 |
RP | 77.60 ± 35.45 | 60.00 ± 38.13 | 2.365 | 0.020 |
BP | 81.25 ± 11.23 | 75.40 ± 14.17 | 2.259 | 0.026 |
GH | 56.77 ± 18.49 | 46.20 ± 17.63 | 2.897 | 0.005 |
VT | 72.92 ± 12.88 | 62.10 ± 17.16 | 3.544* | 0.001 |
SF | 75.78 ± 23.55 | 70.50 ± 22.69 | 1.131 | 0.261 |
RE | 81.25 ± 31.44 | 67.33 ± 38.39 | 1.959 | 0.053 |
MH | 71.33 ± 13.96 | 62.16 ± 14.88 | 3.144 | 0.002 |
HT | 53.65 ± 23.06 | 44.00 ± 20.55 | 2.188 | 0.031 |
PCS | 45.88 ± 12.62 | 42.92 ± 14.23 | 1.088 | 0.279 |
MCS | 48.09 ± 9.89 | 41.23 ± 15.73 | 2.596* | 0.011 |
SDS | 42.79 ± 8.65 | 49.68 ± 10.52 | −3.532 | 0.001 |
SAS | 37.89 ± 7.08 | 43.68 ± 8.42 | −3.675 | 0.000 |